Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-044487
Filing Date
2025-03-25
Accepted
2025-03-25 16:44:32
Documents
108
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rkda-20241231.htm   iXBRL 10-K 3798837
2 EX-4.7 rkda-ex4_7.htm EX-4.7 48497
3 EX-23.1 rkda-ex23_1.htm EX-23.1 5004
4 EX-31.1 rkda-ex31_1.htm EX-31.1 17286
5 EX-31.2 rkda-ex31_2.htm EX-31.2 17259
6 EX-32.1 rkda-ex32_1.htm EX-32.1 8135
7 EX-32.2 rkda-ex32_2.htm EX-32.2 8120
  Complete submission text file 0000950170-25-044487.txt   17267075

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20241231.xsd EX-101.SCH 2680104
111 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20241231_htm.xml XML 3374383
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37383 | Film No.: 25768937
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)